Cargando…
Mucosa‐associated lymphoid tissue lymphoma translocation protein 1 in rheumatoid arthritis: Longitudinal change after treatment and correlation with treatment efficacy of tumor necrosis factor inhibitors
BACKGROUND: Mucosa‐associated lymphoid tissue lymphoma translocation protein 1 (MALT1) correlates with treatment outcomes in inflammatory bowel disease and rheumatoid arthritis (RA). This study aimed to further evaluate the MALT1 longitudinal change and its relationship with tumor necrosis factor in...
Autores principales: | Wang, Feng, Liu, Gaozhan, Xiang, Lei, Yuan, Jie, Tao, Ying, Zhang, Lin, Zhang, Anbing, Chang, Xiuli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169166/ https://www.ncbi.nlm.nih.gov/pubmed/35500150 http://dx.doi.org/10.1002/jcla.24449 |
Ejemplares similares
-
Mucosa-associated lymphoid tissue lymphoma translocation 1 as a novel therapeutic target for rheumatoid arthritis
por: Lee, Chang Hoon, et al.
Publicado: (2017) -
MALT1 positively relates to Th17 cells, inflammation/activity degree, and its decrement along with treatment reflects TNF inhibitor response in ankylosing spondylitis patients
por: Yuan, Jie, et al.
Publicado: (2022) -
The Role of Radiotherapy in the Treatment of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
por: Nam, Taek-Keun, et al.
Publicado: (2014) -
Diagnosis and Treatment for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma
por: Nakamura, Shotaro, et al.
Publicado: (2022) -
Colonic Mucosa-Associated Lymphoid Tissue Lymphoma
por: Akasaka, Risaburo, et al.
Publicado: (2012)